Bladder Diseases
6
0
0
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
33.3%
2 terminated out of 6 trials
60.0%
-26.5% vs benchmark
17%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)
Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic Cystitis
Pelvic Floor Muscle Training (PFMT) in Treatment and Prevention of POP (POP Study)
Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)
Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium
Study of U101 for Bladder Pain and/or Urgency